Global Cell and Gene Therapy Drug Delivery Devices Supply, Demand and Key Producers, 2023-2029

Page: 118

Published Date: 05 Feb 2023

Category: Medical Devices & Consumables

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Related Reports
Product Tags

Description

The global Cell and Gene Therapy Drug Delivery Devices market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Cell and gene therapy drug delivery industry is a transformative industry whose full potential is only just beginning to emerge. Cell and gene therapy involves the extraction of cells, protein, or genetic material (DNA) from the donor, and altering them to provide highly personalized therapy. Cell and gene therapies may offer longer-lasting effects than traditional medicines. One of the significant drugs of the cell and gene therapy industry is CAR-T cell-based medicines, which include both cell therapy and gene therapy. Various market players are actively investing in the research and development of the cell and gene therapy industry. The players are offering improved and new products, which meet the critical needs of patients.

This report studies the global Cell and Gene Therapy Drug Delivery Devices demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Cell and Gene Therapy Drug Delivery Devices, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Cell and Gene Therapy Drug Delivery Devices that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Cell and Gene Therapy Drug Delivery Devices total market, 2018-2029, (USD Million)
Global Cell and Gene Therapy Drug Delivery Devices total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Cell and Gene Therapy Drug Delivery Devices total market, key domestic companies and share, (USD Million)
Global Cell and Gene Therapy Drug Delivery Devices revenue by player and market share 2018-2023, (USD Million)
Global Cell and Gene Therapy Drug Delivery Devices total market by Type, CAGR, 2018-2029, (USD Million)
Global Cell and Gene Therapy Drug Delivery Devices total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Cell and Gene Therapy Drug Delivery Devices market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Amgen, Inc., Bausch and Lomb Incorporated, Becton, Dickinson and Company, Bluebird bio, Inc., Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.), Dendreon Pharmaceuticals LLC., Helixmith Co., Ltd (ViroMed Co., Ltd), Human Stem Cell Institute and Kite Pharma, Inc., etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Cell and Gene Therapy Drug Delivery Devices market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Cell and Gene Therapy Drug Delivery Devices Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Cell and Gene Therapy Drug Delivery Devices Market, Segmentation by Type
Sterile Insulin Syringe
Pre-Filled Syringe
Infusion Bags

Global Cell and Gene Therapy Drug Delivery Devices Market, Segmentation by Application
Luxturna
Kymriah
Provenge
Zolgensma
Yescarta
Strimvelis

Companies Profiled:
Amgen, Inc.
Bausch and Lomb Incorporated
Becton, Dickinson and Company
Bluebird bio, Inc.
Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.)
Dendreon Pharmaceuticals LLC.
Helixmith Co., Ltd (ViroMed Co., Ltd)
Human Stem Cell Institute
Kite Pharma, Inc.
Kolon Tissue Gene, inc.
Novartis AG
Orchard Therapeutics plc.
Pfizer, Inc.
Renova Therapeutics
Spark Therapeutics, Inc.
uniQure N.V.
Vericel Corporation

Key Questions Answered
1. How big is the global Cell and Gene Therapy Drug Delivery Devices market?
2. What is the demand of the global Cell and Gene Therapy Drug Delivery Devices market?
3. What is the year over year growth of the global Cell and Gene Therapy Drug Delivery Devices market?
4. What is the total value of the global Cell and Gene Therapy Drug Delivery Devices market?
5. Who are the major players in the global Cell and Gene Therapy Drug Delivery Devices market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Cell and Gene Therapy Drug Delivery Devices Introduction
    1.2 World Cell and Gene Therapy Drug Delivery Devices Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World Cell and Gene Therapy Drug Delivery Devices Total Market by Region (by Headquarter Location)
        1.3.1 World Cell and Gene Therapy Drug Delivery Devices Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States Cell and Gene Therapy Drug Delivery Devices Market Size (2018-2029)
        1.3.3 China Cell and Gene Therapy Drug Delivery Devices Market Size (2018-2029)
        1.3.4 Europe Cell and Gene Therapy Drug Delivery Devices Market Size (2018-2029)
        1.3.5 Japan Cell and Gene Therapy Drug Delivery Devices Market Size (2018-2029)
        1.3.6 South Korea Cell and Gene Therapy Drug Delivery Devices Market Size (2018-2029)
        1.3.7 ASEAN Cell and Gene Therapy Drug Delivery Devices Market Size (2018-2029)
        1.3.8 India Cell and Gene Therapy Drug Delivery Devices Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Cell and Gene Therapy Drug Delivery Devices Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Cell and Gene Therapy Drug Delivery Devices Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Cell and Gene Therapy Drug Delivery Devices Consumption Value (2018-2029)
    2.2 World Cell and Gene Therapy Drug Delivery Devices Consumption Value by Region
        2.2.1 World Cell and Gene Therapy Drug Delivery Devices Consumption Value by Region (2018-2023)
        2.2.2 World Cell and Gene Therapy Drug Delivery Devices Consumption Value Forecast by Region (2024-2029)
    2.3 United States Cell and Gene Therapy Drug Delivery Devices Consumption Value (2018-2029)
    2.4 China Cell and Gene Therapy Drug Delivery Devices Consumption Value (2018-2029)
    2.5 Europe Cell and Gene Therapy Drug Delivery Devices Consumption Value (2018-2029)
    2.6 Japan Cell and Gene Therapy Drug Delivery Devices Consumption Value (2018-2029)
    2.7 South Korea Cell and Gene Therapy Drug Delivery Devices Consumption Value (2018-2029)
    2.8 ASEAN Cell and Gene Therapy Drug Delivery Devices Consumption Value (2018-2029)
    2.9 India Cell and Gene Therapy Drug Delivery Devices Consumption Value (2018-2029)

3 World Cell and Gene Therapy Drug Delivery Devices Companies Competitive Analysis
    3.1 World Cell and Gene Therapy Drug Delivery Devices Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Cell and Gene Therapy Drug Delivery Devices Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Cell and Gene Therapy Drug Delivery Devices in 2022
        3.2.3 Global Concentration Ratios (CR8) for Cell and Gene Therapy Drug Delivery Devices in 2022
    3.3 Cell and Gene Therapy Drug Delivery Devices Company Evaluation Quadrant
    3.4 Cell and Gene Therapy Drug Delivery Devices Market: Overall Company Footprint Analysis
        3.4.1 Cell and Gene Therapy Drug Delivery Devices Market: Region Footprint
        3.4.2 Cell and Gene Therapy Drug Delivery Devices Market: Company Product Type Footprint
        3.4.3 Cell and Gene Therapy Drug Delivery Devices Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Cell and Gene Therapy Drug Delivery Devices Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Cell and Gene Therapy Drug Delivery Devices Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: Cell and Gene Therapy Drug Delivery Devices Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: Cell and Gene Therapy Drug Delivery Devices Consumption Value Comparison
        4.2.1 United States VS China: Cell and Gene Therapy Drug Delivery Devices Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Cell and Gene Therapy Drug Delivery Devices Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based Cell and Gene Therapy Drug Delivery Devices Companies and Market Share, 2018-2023
        4.3.1 United States Based Cell and Gene Therapy Drug Delivery Devices Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Cell and Gene Therapy Drug Delivery Devices Revenue, (2018-2023)
    4.4 China Based Companies Cell and Gene Therapy Drug Delivery Devices Revenue and Market Share, 2018-2023
        4.4.1 China Based Cell and Gene Therapy Drug Delivery Devices Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Cell and Gene Therapy Drug Delivery Devices Revenue, (2018-2023)
    4.5 Rest of World Based Cell and Gene Therapy Drug Delivery Devices Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based Cell and Gene Therapy Drug Delivery Devices Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Cell and Gene Therapy Drug Delivery Devices Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World Cell and Gene Therapy Drug Delivery Devices Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Sterile Insulin Syringe
        5.2.2 Pre-Filled Syringe
        5.2.3 Infusion Bags
    5.3 Market Segment by Type
        5.3.1 World Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2018-2023)
        5.3.2 World Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2024-2029)
        5.3.3 World Cell and Gene Therapy Drug Delivery Devices Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Cell and Gene Therapy Drug Delivery Devices Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Luxturna
        6.2.2 Kymriah
        6.2.3 Provenge
        6.2.4 Zolgensma
        6.2.5 Zolgensma
        6.2.6 Strimvelis
    6.3 Market Segment by Application
        6.3.1 World Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2018-2023)
        6.3.2 World Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2024-2029)
        6.3.3 World Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2018-2029)

7 Company Profiles
    7.1 Amgen, Inc.
        7.1.1 Amgen, Inc. Details
        7.1.2 Amgen, Inc. Major Business
        7.1.3 Amgen, Inc. Cell and Gene Therapy Drug Delivery Devices Product and Services
        7.1.4 Amgen, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 Amgen, Inc. Recent Developments/Updates
        7.1.6 Amgen, Inc. Competitive Strengths & Weaknesses
    7.2 Bausch and Lomb Incorporated
        7.2.1 Bausch and Lomb Incorporated Details
        7.2.2 Bausch and Lomb Incorporated Major Business
        7.2.3 Bausch and Lomb Incorporated Cell and Gene Therapy Drug Delivery Devices Product and Services
        7.2.4 Bausch and Lomb Incorporated Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 Bausch and Lomb Incorporated Recent Developments/Updates
        7.2.6 Bausch and Lomb Incorporated Competitive Strengths & Weaknesses
    7.3 Becton, Dickinson and Company
        7.3.1 Becton, Dickinson and Company Details
        7.3.2 Becton, Dickinson and Company Major Business
        7.3.3 Becton, Dickinson and Company Cell and Gene Therapy Drug Delivery Devices Product and Services
        7.3.4 Becton, Dickinson and Company Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 Becton, Dickinson and Company Recent Developments/Updates
        7.3.6 Becton, Dickinson and Company Competitive Strengths & Weaknesses
    7.4 Bluebird bio, Inc.
        7.4.1 Bluebird bio, Inc. Details
        7.4.2 Bluebird bio, Inc. Major Business
        7.4.3 Bluebird bio, Inc. Cell and Gene Therapy Drug Delivery Devices Product and Services
        7.4.4 Bluebird bio, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 Bluebird bio, Inc. Recent Developments/Updates
        7.4.6 Bluebird bio, Inc. Competitive Strengths & Weaknesses
    7.5 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.)
        7.5.1 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Details
        7.5.2 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Major Business
        7.5.3 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Cell and Gene Therapy Drug Delivery Devices Product and Services
        7.5.4 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Recent Developments/Updates
        7.5.6 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Competitive Strengths & Weaknesses
    7.6 Dendreon Pharmaceuticals LLC.
        7.6.1 Dendreon Pharmaceuticals LLC. Details
        7.6.2 Dendreon Pharmaceuticals LLC. Major Business
        7.6.3 Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Drug Delivery Devices Product and Services
        7.6.4 Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 Dendreon Pharmaceuticals LLC. Recent Developments/Updates
        7.6.6 Dendreon Pharmaceuticals LLC. Competitive Strengths & Weaknesses
    7.7 Helixmith Co., Ltd (ViroMed Co., Ltd)
        7.7.1 Helixmith Co., Ltd (ViroMed Co., Ltd) Details
        7.7.2 Helixmith Co., Ltd (ViroMed Co., Ltd) Major Business
        7.7.3 Helixmith Co., Ltd (ViroMed Co., Ltd) Cell and Gene Therapy Drug Delivery Devices Product and Services
        7.7.4 Helixmith Co., Ltd (ViroMed Co., Ltd) Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2018-2023)
        7.7.5 Helixmith Co., Ltd (ViroMed Co., Ltd) Recent Developments/Updates
        7.7.6 Helixmith Co., Ltd (ViroMed Co., Ltd) Competitive Strengths & Weaknesses
    7.8 Human Stem Cell Institute
        7.8.1 Human Stem Cell Institute Details
        7.8.2 Human Stem Cell Institute Major Business
        7.8.3 Human Stem Cell Institute Cell and Gene Therapy Drug Delivery Devices Product and Services
        7.8.4 Human Stem Cell Institute Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2018-2023)
        7.8.5 Human Stem Cell Institute Recent Developments/Updates
        7.8.6 Human Stem Cell Institute Competitive Strengths & Weaknesses
    7.9 Kite Pharma, Inc.
        7.9.1 Kite Pharma, Inc. Details
        7.9.2 Kite Pharma, Inc. Major Business
        7.9.3 Kite Pharma, Inc. Cell and Gene Therapy Drug Delivery Devices Product and Services
        7.9.4 Kite Pharma, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2018-2023)
        7.9.5 Kite Pharma, Inc. Recent Developments/Updates
        7.9.6 Kite Pharma, Inc. Competitive Strengths & Weaknesses
    7.10 Kolon Tissue Gene, inc.
        7.10.1 Kolon Tissue Gene, inc. Details
        7.10.2 Kolon Tissue Gene, inc. Major Business
        7.10.3 Kolon Tissue Gene, inc. Cell and Gene Therapy Drug Delivery Devices Product and Services
        7.10.4 Kolon Tissue Gene, inc. Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2018-2023)
        7.10.5 Kolon Tissue Gene, inc. Recent Developments/Updates
        7.10.6 Kolon Tissue Gene, inc. Competitive Strengths & Weaknesses
    7.11 Novartis AG
        7.11.1 Novartis AG Details
        7.11.2 Novartis AG Major Business
        7.11.3 Novartis AG Cell and Gene Therapy Drug Delivery Devices Product and Services
        7.11.4 Novartis AG Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2018-2023)
        7.11.5 Novartis AG Recent Developments/Updates
        7.11.6 Novartis AG Competitive Strengths & Weaknesses
    7.12 Orchard Therapeutics plc.
        7.12.1 Orchard Therapeutics plc. Details
        7.12.2 Orchard Therapeutics plc. Major Business
        7.12.3 Orchard Therapeutics plc. Cell and Gene Therapy Drug Delivery Devices Product and Services
        7.12.4 Orchard Therapeutics plc. Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2018-2023)
        7.12.5 Orchard Therapeutics plc. Recent Developments/Updates
        7.12.6 Orchard Therapeutics plc. Competitive Strengths & Weaknesses
    7.13 Pfizer, Inc.
        7.13.1 Pfizer, Inc. Details
        7.13.2 Pfizer, Inc. Major Business
        7.13.3 Pfizer, Inc. Cell and Gene Therapy Drug Delivery Devices Product and Services
        7.13.4 Pfizer, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2018-2023)
        7.13.5 Pfizer, Inc. Recent Developments/Updates
        7.13.6 Pfizer, Inc. Competitive Strengths & Weaknesses
    7.14 Renova Therapeutics
        7.14.1 Renova Therapeutics Details
        7.14.2 Renova Therapeutics Major Business
        7.14.3 Renova Therapeutics Cell and Gene Therapy Drug Delivery Devices Product and Services
        7.14.4 Renova Therapeutics Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2018-2023)
        7.14.5 Renova Therapeutics Recent Developments/Updates
        7.14.6 Renova Therapeutics Competitive Strengths & Weaknesses
    7.15 Spark Therapeutics, Inc.
        7.15.1 Spark Therapeutics, Inc. Details
        7.15.2 Spark Therapeutics, Inc. Major Business
        7.15.3 Spark Therapeutics, Inc. Cell and Gene Therapy Drug Delivery Devices Product and Services
        7.15.4 Spark Therapeutics, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2018-2023)
        7.15.5 Spark Therapeutics, Inc. Recent Developments/Updates
        7.15.6 Spark Therapeutics, Inc. Competitive Strengths & Weaknesses
    7.16 uniQure N.V.
        7.16.1 uniQure N.V. Details
        7.16.2 uniQure N.V. Major Business
        7.16.3 uniQure N.V. Cell and Gene Therapy Drug Delivery Devices Product and Services
        7.16.4 uniQure N.V. Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2018-2023)
        7.16.5 uniQure N.V. Recent Developments/Updates
        7.16.6 uniQure N.V. Competitive Strengths & Weaknesses
    7.17 Vericel Corporation
        7.17.1 Vericel Corporation Details
        7.17.2 Vericel Corporation Major Business
        7.17.3 Vericel Corporation Cell and Gene Therapy Drug Delivery Devices Product and Services
        7.17.4 Vericel Corporation Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2018-2023)
        7.17.5 Vericel Corporation Recent Developments/Updates
        7.17.6 Vericel Corporation Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Cell and Gene Therapy Drug Delivery Devices Industry Chain
    8.2 Cell and Gene Therapy Drug Delivery Devices Upstream Analysis
    8.3 Cell and Gene Therapy Drug Delivery Devices Midstream Analysis
    8.4 Cell and Gene Therapy Drug Delivery Devices Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Cell and Gene Therapy Drug Delivery Devices Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World Cell and Gene Therapy Drug Delivery Devices Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World Cell and Gene Therapy Drug Delivery Devices Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World Cell and Gene Therapy Drug Delivery Devices Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World Cell and Gene Therapy Drug Delivery Devices Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Cell and Gene Therapy Drug Delivery Devices Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World Cell and Gene Therapy Drug Delivery Devices Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World Cell and Gene Therapy Drug Delivery Devices Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World Cell and Gene Therapy Drug Delivery Devices Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key Cell and Gene Therapy Drug Delivery Devices Players in 2022
    Table 12. World Cell and Gene Therapy Drug Delivery Devices Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global Cell and Gene Therapy Drug Delivery Devices Company Evaluation Quadrant
    Table 14. Head Office of Key Cell and Gene Therapy Drug Delivery Devices Player
    Table 15. Cell and Gene Therapy Drug Delivery Devices Market: Company Product Type Footprint
    Table 16. Cell and Gene Therapy Drug Delivery Devices Market: Company Product Application Footprint
    Table 17. Cell and Gene Therapy Drug Delivery Devices Mergers & Acquisitions Activity
    Table 18. United States VS China Cell and Gene Therapy Drug Delivery Devices Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China Cell and Gene Therapy Drug Delivery Devices Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based Cell and Gene Therapy Drug Delivery Devices Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Cell and Gene Therapy Drug Delivery Devices Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies Cell and Gene Therapy Drug Delivery Devices Revenue Market Share (2018-2023)
    Table 23. China Based Cell and Gene Therapy Drug Delivery Devices Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Cell and Gene Therapy Drug Delivery Devices Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies Cell and Gene Therapy Drug Delivery Devices Revenue Market Share (2018-2023)
    Table 26. Rest of World Based Cell and Gene Therapy Drug Delivery Devices Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Cell and Gene Therapy Drug Delivery Devices Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies Cell and Gene Therapy Drug Delivery Devices Revenue Market Share (2018-2023)
    Table 29. World Cell and Gene Therapy Drug Delivery Devices Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2018-2023) & (USD Million)
    Table 31. World Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2024-2029) & (USD Million)
    Table 32. World Cell and Gene Therapy Drug Delivery Devices Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2018-2023) & (USD Million)
    Table 34. World Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2024-2029) & (USD Million)
    Table 35. Amgen, Inc. Basic Information, Area Served and Competitors
    Table 36. Amgen, Inc. Major Business
    Table 37. Amgen, Inc. Cell and Gene Therapy Drug Delivery Devices Product and Services
    Table 38. Amgen, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. Amgen, Inc. Recent Developments/Updates
    Table 40. Amgen, Inc. Competitive Strengths & Weaknesses
    Table 41. Bausch and Lomb Incorporated Basic Information, Area Served and Competitors
    Table 42. Bausch and Lomb Incorporated Major Business
    Table 43. Bausch and Lomb Incorporated Cell and Gene Therapy Drug Delivery Devices Product and Services
    Table 44. Bausch and Lomb Incorporated Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. Bausch and Lomb Incorporated Recent Developments/Updates
    Table 46. Bausch and Lomb Incorporated Competitive Strengths & Weaknesses
    Table 47. Becton, Dickinson and Company Basic Information, Area Served and Competitors
    Table 48. Becton, Dickinson and Company Major Business
    Table 49. Becton, Dickinson and Company Cell and Gene Therapy Drug Delivery Devices Product and Services
    Table 50. Becton, Dickinson and Company Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. Becton, Dickinson and Company Recent Developments/Updates
    Table 52. Becton, Dickinson and Company Competitive Strengths & Weaknesses
    Table 53. Bluebird bio, Inc. Basic Information, Area Served and Competitors
    Table 54. Bluebird bio, Inc. Major Business
    Table 55. Bluebird bio, Inc. Cell and Gene Therapy Drug Delivery Devices Product and Services
    Table 56. Bluebird bio, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. Bluebird bio, Inc. Recent Developments/Updates
    Table 58. Bluebird bio, Inc. Competitive Strengths & Weaknesses
    Table 59. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Basic Information, Area Served and Competitors
    Table 60. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Major Business
    Table 61. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Cell and Gene Therapy Drug Delivery Devices Product and Services
    Table 62. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Recent Developments/Updates
    Table 64. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Competitive Strengths & Weaknesses
    Table 65. Dendreon Pharmaceuticals LLC. Basic Information, Area Served and Competitors
    Table 66. Dendreon Pharmaceuticals LLC. Major Business
    Table 67. Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Drug Delivery Devices Product and Services
    Table 68. Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 69. Dendreon Pharmaceuticals LLC. Recent Developments/Updates
    Table 70. Dendreon Pharmaceuticals LLC. Competitive Strengths & Weaknesses
    Table 71. Helixmith Co., Ltd (ViroMed Co., Ltd) Basic Information, Area Served and Competitors
    Table 72. Helixmith Co., Ltd (ViroMed Co., Ltd) Major Business
    Table 73. Helixmith Co., Ltd (ViroMed Co., Ltd) Cell and Gene Therapy Drug Delivery Devices Product and Services
    Table 74. Helixmith Co., Ltd (ViroMed Co., Ltd) Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 75. Helixmith Co., Ltd (ViroMed Co., Ltd) Recent Developments/Updates
    Table 76. Helixmith Co., Ltd (ViroMed Co., Ltd) Competitive Strengths & Weaknesses
    Table 77. Human Stem Cell Institute Basic Information, Area Served and Competitors
    Table 78. Human Stem Cell Institute Major Business
    Table 79. Human Stem Cell Institute Cell and Gene Therapy Drug Delivery Devices Product and Services
    Table 80. Human Stem Cell Institute Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 81. Human Stem Cell Institute Recent Developments/Updates
    Table 82. Human Stem Cell Institute Competitive Strengths & Weaknesses
    Table 83. Kite Pharma, Inc. Basic Information, Area Served and Competitors
    Table 84. Kite Pharma, Inc. Major Business
    Table 85. Kite Pharma, Inc. Cell and Gene Therapy Drug Delivery Devices Product and Services
    Table 86. Kite Pharma, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 87. Kite Pharma, Inc. Recent Developments/Updates
    Table 88. Kite Pharma, Inc. Competitive Strengths & Weaknesses
    Table 89. Kolon Tissue Gene, inc. Basic Information, Area Served and Competitors
    Table 90. Kolon Tissue Gene, inc. Major Business
    Table 91. Kolon Tissue Gene, inc. Cell and Gene Therapy Drug Delivery Devices Product and Services
    Table 92. Kolon Tissue Gene, inc. Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 93. Kolon Tissue Gene, inc. Recent Developments/Updates
    Table 94. Kolon Tissue Gene, inc. Competitive Strengths & Weaknesses
    Table 95. Novartis AG Basic Information, Area Served and Competitors
    Table 96. Novartis AG Major Business
    Table 97. Novartis AG Cell and Gene Therapy Drug Delivery Devices Product and Services
    Table 98. Novartis AG Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 99. Novartis AG Recent Developments/Updates
    Table 100. Novartis AG Competitive Strengths & Weaknesses
    Table 101. Orchard Therapeutics plc. Basic Information, Area Served and Competitors
    Table 102. Orchard Therapeutics plc. Major Business
    Table 103. Orchard Therapeutics plc. Cell and Gene Therapy Drug Delivery Devices Product and Services
    Table 104. Orchard Therapeutics plc. Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 105. Orchard Therapeutics plc. Recent Developments/Updates
    Table 106. Orchard Therapeutics plc. Competitive Strengths & Weaknesses
    Table 107. Pfizer, Inc. Basic Information, Area Served and Competitors
    Table 108. Pfizer, Inc. Major Business
    Table 109. Pfizer, Inc. Cell and Gene Therapy Drug Delivery Devices Product and Services
    Table 110. Pfizer, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 111. Pfizer, Inc. Recent Developments/Updates
    Table 112. Pfizer, Inc. Competitive Strengths & Weaknesses
    Table 113. Renova Therapeutics Basic Information, Area Served and Competitors
    Table 114. Renova Therapeutics Major Business
    Table 115. Renova Therapeutics Cell and Gene Therapy Drug Delivery Devices Product and Services
    Table 116. Renova Therapeutics Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 117. Renova Therapeutics Recent Developments/Updates
    Table 118. Renova Therapeutics Competitive Strengths & Weaknesses
    Table 119. Spark Therapeutics, Inc. Basic Information, Area Served and Competitors
    Table 120. Spark Therapeutics, Inc. Major Business
    Table 121. Spark Therapeutics, Inc. Cell and Gene Therapy Drug Delivery Devices Product and Services
    Table 122. Spark Therapeutics, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 123. Spark Therapeutics, Inc. Recent Developments/Updates
    Table 124. Spark Therapeutics, Inc. Competitive Strengths & Weaknesses
    Table 125. uniQure N.V. Basic Information, Area Served and Competitors
    Table 126. uniQure N.V. Major Business
    Table 127. uniQure N.V. Cell and Gene Therapy Drug Delivery Devices Product and Services
    Table 128. uniQure N.V. Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 129. uniQure N.V. Recent Developments/Updates
    Table 130. Vericel Corporation Basic Information, Area Served and Competitors
    Table 131. Vericel Corporation Major Business
    Table 132. Vericel Corporation Cell and Gene Therapy Drug Delivery Devices Product and Services
    Table 133. Vericel Corporation Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 134. Global Key Players of Cell and Gene Therapy Drug Delivery Devices Upstream (Raw Materials)
    Table 135. Cell and Gene Therapy Drug Delivery Devices Typical Customers
List of Figure
    Figure 1. Cell and Gene Therapy Drug Delivery Devices Picture
    Figure 2. World Cell and Gene Therapy Drug Delivery Devices Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Cell and Gene Therapy Drug Delivery Devices Total Market Size (2018-2029) & (USD Million)
    Figure 4. World Cell and Gene Therapy Drug Delivery Devices Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World Cell and Gene Therapy Drug Delivery Devices Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company Cell and Gene Therapy Drug Delivery Devices Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company Cell and Gene Therapy Drug Delivery Devices Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company Cell and Gene Therapy Drug Delivery Devices Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company Cell and Gene Therapy Drug Delivery Devices Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company Cell and Gene Therapy Drug Delivery Devices Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company Cell and Gene Therapy Drug Delivery Devices Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company Cell and Gene Therapy Drug Delivery Devices Revenue (2018-2029) & (USD Million)
    Figure 13. Cell and Gene Therapy Drug Delivery Devices Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Cell and Gene Therapy Drug Delivery Devices Consumption Value (2018-2029) & (USD Million)
    Figure 16. World Cell and Gene Therapy Drug Delivery Devices Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States Cell and Gene Therapy Drug Delivery Devices Consumption Value (2018-2029) & (USD Million)
    Figure 18. China Cell and Gene Therapy Drug Delivery Devices Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Cell and Gene Therapy Drug Delivery Devices Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan Cell and Gene Therapy Drug Delivery Devices Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea Cell and Gene Therapy Drug Delivery Devices Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN Cell and Gene Therapy Drug Delivery Devices Consumption Value (2018-2029) & (USD Million)
    Figure 23. India Cell and Gene Therapy Drug Delivery Devices Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of Cell and Gene Therapy Drug Delivery Devices by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Cell and Gene Therapy Drug Delivery Devices Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Cell and Gene Therapy Drug Delivery Devices Markets in 2022
    Figure 27. United States VS China: Cell and Gene Therapy Drug Delivery Devices Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Cell and Gene Therapy Drug Delivery Devices Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World Cell and Gene Therapy Drug Delivery Devices Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World Cell and Gene Therapy Drug Delivery Devices Market Size Market Share by Type in 2022
    Figure 31. Sterile Insulin Syringe
    Figure 32. Pre-Filled Syringe
    Figure 33. Infusion Bags
    Figure 34. World Cell and Gene Therapy Drug Delivery Devices Market Size Market Share by Type (2018-2029)
    Figure 35. World Cell and Gene Therapy Drug Delivery Devices Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 36. World Cell and Gene Therapy Drug Delivery Devices Market Size Market Share by Application in 2022
    Figure 37. Luxturna
    Figure 38. Kymriah
    Figure 39. Provenge
    Figure 40. Zolgensma
    Figure 41. Yescarta
    Figure 42. Strimvelis
    Figure 43. Cell and Gene Therapy Drug Delivery Devices Industrial Chain
    Figure 44. Methodology
    Figure 45. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Related Reports

Global Cell and Gene Therapy Drug Delivery Devices Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Cell and Gene Therapy Drug Delivery Devices Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 10 Jan 2023

date Medical Devices & Consumables

Global Cell and Gene Therapy Drug Delivery Devices Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Cell and Gene Therapy Drug Delivery Devices Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 03 Jan 2024

date Medical Devices & Consumables

According to our (Global Info Research) latest study, the global Cell and Gene Therapy Drug Delivery Devices market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Global Cell and Gene Therapy Drug Delivery Devices Supply, Demand and Key Producers, 2024-2030

Global Cell and Gene Therapy Drug Delivery Devices Supply, Demand and Key Producers, 2024-2030

date 12 Feb 2024

date Medical Devices & Consumables

The global Cell and Gene Therapy Drug Delivery Devices market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

Product Tags

Cell and Gene Therapy Drug Delivery Devices

Blood Plasma Refrigerator

ENT Camera System

Medical Repair Titanium Mesh

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>